382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study

382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S711
Main Authors: Valladares, M., Safont Aguileria, M.J., González-Flores, E., García Alfonso, P., López Muñoz, A.M., Aranda Aguilar, E., Falco Ferrer, E., Rodriguez-Salas, N., Cirera, L., Llanos-Munoz, M., Aparicio, J., Pimentel, P., Castillo Trujillo, A.O., Salgado Fernandez, M., Salud Salvia, M.A., Vidal Tocino, R., Massuti Sureda, B., Garcia-Carbonero, R., Vicente Conesa, M.A.D.L.A., Lloansi Vila, A.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.520